Skip to Content

Health Highlights: April 12, 2018

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Former U.S. House Speaker Boehner Now Backs Marijuana Legalization, Joins Cannabis Company Board

Former U.S. House Speaker John Boehner used to oppose marijuana legalization but has changed his stance and is now involved with a marijuana company.

The 68-year-old Ohio Republican has joined the advisory board of cannabis company Acreage Holdings, the Associated Press reported.

"I decided to get involved because of the struggles of our country's veterans and the opioid epidemic, after learning how descheduling the drug can potentially help with both crises," Boehner said in a statement released Wednesday.

He's now in favor of federally-funded marijuana research and allowing the Department of Veterans Affairs to offer the drug as a treatment for conditions such as chronic pain and post-traumatic stress disorder, the AP reported.

Former Massachusetts Republican Gov. William Weld has also joined the advisory board of Acreage Holdings, which has cannabis operations in 11 states. In the 2016 presidential election, Weld ran on the Libertarian Party ticket that was headed by legal-marijuana advocate Gary Johnson.

Boehner and Weld will serve on its board of directors when that is formed, the company said.

© 2020 HealthDay. All rights reserved.

Posted: April 2018

Read this next

1 in 3 High School Seniors Who Misuse Prescription Opioids Turn to Heroin

TUESDAY, Oct. 27, 2020 -- Among high school seniors, nearly a third of those who misuse prescription opioids use heroin by age 35, a new study shows. "It is a very timely study...

Signs America's Opioid Epidemic Might Finally Be Waning

SATURDAY, Oct. 3, 2020 -- Here's some heartening news on the opioid painkillers front: Abuse of the prescription medicines in the United States fell by more than one-quarter...

Was FDA Lax in Approving Opioids Too Easily?

WEDNESDAY, Sept. 30, 2020 -- For at least two decades, the U.S. Food and Drug Administration has been approving new formulations of prescription opioids without requiring drug...